Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

208 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.
Neuschwander-Tetri BA, Caldwell SH. Neuschwander-Tetri BA, et al. Among authors: caldwell sh. Hepatology. 2003 May;37(5):1202-19. doi: 10.1053/jhep.2003.50193. Hepatology. 2003. PMID: 12717402 Review.
Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members.
Caldwell SH, Leung PS, Spivey JR, Prindiville T, de Medina M, Saicheur T, Rowley M, Reddy KR, Coppel R, Jeffers LJ, et al. Caldwell SH, et al. Hepatology. 1992 Oct;16(4):899-905. doi: 10.1002/hep.1840160408. Hepatology. 1992. PMID: 1398496
Predictive value of intraoperative biopsies and liver function tests for preservation injury in orthotopic liver transplantation.
Gaffey MJ, Boyd JC, Traweek ST, Ali MA, Rezeig M, Caldwell SH, Iezzoni JC, McCullough C, Stevenson WC, Khuroo S, Nezamuddin N, Ishitani MB, Pruett TL. Gaffey MJ, et al. Among authors: caldwell sh. Hepatology. 1997 Jan;25(1):184-9. doi: 10.1002/hep.510250134. Hepatology. 1997. PMID: 8985288
Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Caldwell SH, et al. Hepatology. 1999 Mar;29(3):664-9. doi: 10.1002/hep.510290347. Hepatology. 1999. PMID: 10051466
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.
Perrillo R, Rakela J, Dienstag J, Levy G, Martin P, Wright T, Caldwell S, Schiff E, Gish R, Villeneuve JP, Farr G, Anschuetz G, Crowther L, Brown N. Perrillo R, et al. Among authors: caldwell s. Hepatology. 1999 May;29(5):1581-6. doi: 10.1002/hep.510290507. Hepatology. 1999. PMID: 10216146 Clinical Trial.
Mitochondrial abnormalities in non-alcoholic steatohepatitis.
Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, Parker WD Jr. Caldwell SH, et al. J Hepatol. 1999 Sep;31(3):430-4. doi: 10.1016/s0168-8278(99)80033-6. J Hepatol. 1999. PMID: 10488700
Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds.
Struben VM, Hespenheide EE, Caldwell SH. Struben VM, et al. Among authors: caldwell sh. Am J Med. 2000 Jan;108(1):9-13. doi: 10.1016/s0002-9343(99)00315-0. Am J Med. 2000. PMID: 11059435
A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.
Caldwell SH, Hespenheide EE, Redick JA, Iezzoni JC, Battle EH, Sheppard BL. Caldwell SH, et al. Am J Gastroenterol. 2001 Feb;96(2):519-25. doi: 10.1111/j.1572-0241.2001.03553.x. Am J Gastroenterol. 2001. PMID: 11232700
Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG. Shami VM, et al. Among authors: caldwell sh. Liver Transpl. 2003 Feb;9(2):138-43. doi: 10.1053/jlts.2003.50017. Liver Transpl. 2003. PMID: 12548507
Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials.
Caldwell SH, Chang C, Macik BG. Caldwell SH, et al. Hepatology. 2004 Mar;39(3):592-8. doi: 10.1002/hep.20123. Hepatology. 2004. PMID: 14999675 Review.
208 results
Jump to page